Vaxcyte, Inc. (PCVX)
NGS · Common · CUSIP 92243G108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PCVX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
92243G108
IPO
6/12/2020 · $16.00/share
Business: Vaxcyte, Inc. is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company utilizes a cell-free protein synthesis platform to enable us to uniquely design and produce protein carriers and antigens, the critical building blocks of vaccines.

Company Contact

CEO
Grant Pickering
CFO
Andrew Guggenhime
Headquarters
353 Hatch Drive, Foster City, CA 94404
Phone
650-837-0111
Investor Relations
Andrew Guggenhime · 650-837-0111 · investors@vaxcyte.com
SEC EDGAR Filings
View filings »